Display options
Share it on

Int J Obstet Anesth. 2012 Oct;21(4):339-47. doi: 10.1016/j.ijoa.2012.06.010. Epub 2012 Aug 28.

Maternal and preterm fetal sheep responses to dexmedetomidine.

International journal of obstetric anesthesia

K Uemura, K Shimazutsu, R J McClaine, D J McClaine, R J Manson, W D White, P B Benni, J D Reynolds

Affiliations

  1. Department of Anesthesiology, Duke University Medical Centre, Durham, NC, USA.

PMID: 22938943 PMCID: PMC3462238 DOI: 10.1016/j.ijoa.2012.06.010

Abstract

BACKGROUND: The α(2) adrenergic receptor agonist dexmedetomidine has some unique pharmacologic properties that could benefit pregnant patients (and their fetuses) when they require sedation, analgesia, and/or anesthesia during pregnancy. The purpose of the present study was to delineate maternal and fetal responses to an intravenous infusion of dexmedetomidine.

METHODS: This study was conducted on surgically-recovered preterm sheep instrumented for physiologic recording and blood sampling. Maternal and fetal cardiovascular and blood gas parameters and fetal cerebral oxygenation levels were recorded before, during, and after 3h of dexmedetomidine infusion to the ewe at a rate of 1 μg/kg/h.

RESULTS: Drug infusion produced overt sedation but no apparent respiratory depression as evidenced by stable maternal arterial blood gases; fetal blood gases were also stable. The one blood parameter to change was serum glucose, By the end of the 3-h infusion, glucose increased from 49±10 to 104±33mg/dL in the ewe and from 22±3 to 48±16mg/dL in the fetus; it declined post-drug exposure but remained elevated compared to the starting levels (maternal, 63±12mg/dL, P=0.0497; and fetal, 24±4mg/dL, P=0.012). With respect to cardiovascular status, dexmedetomidine produced a decrease in maternal blood pressure and heart rate with fluctuations in uterine blood flow but had no discernable effect on fetal heart rate or mean arterial pressure. Likewise, maternal drug infusion had no effect on fetal cerebral oxygenation, as measured by in utero near-infrared spectroscopy.

CONCLUSIONS: Using a clinically-relevant dosing regimen, intravenous infusion of dexmedetomidine produced significant maternal sedation without altering fetal physiologic status. Results from this initial acute assessment support the conduct of further studies to determine if dexmedetomidine has clinical utility for sedation and pain control during pregnancy.

Copyright © 2012 Elsevier Ltd. All rights reserved.

References

  1. Anesth Analg. 2001 May;92(5):1251-3 - PubMed
  2. Acta Anaesthesiol Scand. 1997 Feb;41(2):313-9 - PubMed
  3. BJOG. 2008 May;115(6):697-703 - PubMed
  4. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002252 - PubMed
  5. Am J Surg. 2007 Feb;193(2):223-32 - PubMed
  6. Am J Physiol Regul Integr Comp Physiol. 2009 Mar;296(3):R603-9 - PubMed
  7. Curr Surg. 2003 Mar-Apr;60(2):164-73 - PubMed
  8. J Matern Fetal Med. 1996 May-Jun;5(3):106-14 - PubMed
  9. J Cereb Blood Flow Metab. 2005 Aug;25(8):1060-9 - PubMed
  10. Am J Physiol. 1975 Feb;228(2):337-44 - PubMed
  11. Surg Clin North Am. 2008 Apr;88(2):403-19, vii-viii - PubMed
  12. J Clin Anesth. 1993 May-Jun;5(3):194-203 - PubMed
  13. Am J Hypertens. 2010 Nov;23(11):1234-40 - PubMed
  14. J Clin Anesth. 2007 Jun;19(4):280-5 - PubMed
  15. J Chromatogr. 1989 Dec 29;497:282-7 - PubMed
  16. Int J Obstet Anesth. 2009 Jul;18(3):258-61 - PubMed
  17. Am J Physiol Regul Integr Comp Physiol. 2002 Jun;282(6):R1654-62 - PubMed
  18. Clin Pharmacokinet. 2005;44(10):989-1008 - PubMed
  19. Eur J Anaesthesiol. 2011 Jan;28(1):3-6 - PubMed
  20. J Neurosci. 1994 Jul;14(7):4064-78 - PubMed
  21. Rev Bras Anestesiol. 2005 Apr;55(2):212-6 - PubMed
  22. Anaesthesia. 1999 Dec;54(12):1136-42 - PubMed
  23. Br J Anaesth. 2005 Jun;94(6):821-4 - PubMed
  24. Am J Obstet Gynecol. 1989 Feb;160(2):471-6 - PubMed
  25. Obstet Gynecol. 2008 Sep;112(3):661-6 - PubMed
  26. Curr Opin Crit Care. 2001 Aug;7(4):221-6 - PubMed
  27. Br J Anaesth. 2011 Dec;107 Suppl 1:i72-8 - PubMed
  28. Surg Clin North Am. 2008 Apr;88(2):361-90, vii - PubMed
  29. Comp Biochem Physiol A Comp Physiol. 1991;100(4):877-80 - PubMed
  30. Intensive Care Med. 2010 Jun;36(6):926-39 - PubMed
  31. Anesthesiology. 2008 Feb;108(2):225-32 - PubMed
  32. Anesthesiology. 2005 Aug;103(2):269-73 - PubMed
  33. BJOG. 2010 Jun;117(7):837-44 - PubMed
  34. Int J Obstet Anesth. 2009 Jul;18(3):262-7 - PubMed
  35. Anesth Analg. 2002 Aug;95(2):461-6, table of contents - PubMed
  36. Adv Exp Med Biol. 2003;510:187-92 - PubMed
  37. Anesthesiology. 2004 Sep;101(3):744-52 - PubMed
  38. Anesth Analg. 2002 Oct;95(4):1052-9, table of contents - PubMed
  39. J Chromatogr A. 1997 Feb 21;762(1-2):281-91 - PubMed
  40. Anaesthesia. 1999 Feb;54(2):146-65 - PubMed
  41. Int J Obstet Anesth. 2009 Jul;18(3):204-6 - PubMed
  42. Diabetes Care. 2008 May;31(5):1037-9 - PubMed
  43. Anesthesiology. 1974 Jan;40(1):92-6 - PubMed
  44. Anesth Analg. 2007 Feb;104(2):397-406 - PubMed
  45. Can J Anaesth. 2003 Jun-Jul;50(6):607-10 - PubMed
  46. Anesthesiology. 2004 Sep;101(3):787-90 - PubMed
  47. Eur J Obstet Gynecol Reprod Biol. 2007 Mar;131(1):4-12 - PubMed
  48. Int J Obstet Anesth. 2005 Apr;14(2):104-7 - PubMed
  49. Br J Anaesth. 1993 Jul;71(1):108-18 - PubMed
  50. J Matern Fetal Neonatal Med. 2012 Jul;25(7):1160-70 - PubMed
  51. Anesthesiology. 2002 Jan;96(1):134-41 - PubMed
  52. Obstet Gynecol. 1987 Apr;69(4):598-600 - PubMed

Substances

MeSH terms

Publication Types

Grant support